• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Putative hydroxypyruvate isomerase (HYI)

ACP16977

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP16977 Target NameHYI
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-277Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ5T013
Background Information
  • Uniprot Id

    Q5T013

  • Target Species

    Human

  • Target Name

    HYI

  • Target Full Name

    Putative hydroxypyruvate isomerase

  • Target Function

    Catalyzes the reversible isomerization between hydroxypyruvate and 2-hydroxy-3-oxopropanoate (also termed tartronate semialdehyde).

  • Target Protein Families

    Hyi family

  • Target Synonyms

    Endothelial cell apoptosis protein E CE1; Endothelial cell apoptosis protein E-CE1; HT036; Hydroxypyruvate isomerase; Hydroxypyruvate isomerase homolog (E. coli); Hydroxypyruvate isomerase homolog; hyi; HYI_HUMAN; MGC20767; Putative hydroxypyruvate isomerase; RP11 506B15.5

  • Target Background

    This gene encodes a putative hydroxypyruvate isomerase, which likely catalyzes the conversion of hydroxypyruvate to 2-hydroxy-3-oxopropanoate, and may be involved in carbohydrate transport and metabolism. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Inquire Recombinant Human Putative hydroxypyruvate isomerase (HYI) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification